Limited significance of curative surgery in Borrmann type IV gastric cancer

[1]  K. Yamashita,et al.  Survival outcome of Borrmann type IV gastric cancer potentially improved by multimodality treatment. , 2015, Anticancer research.

[2]  K. Yanagihara,et al.  Identification of Novel Transmembrane Proteins in Scirrhous-Type Gastric Cancer by the Escherichia coli Ampicillin Secretion Trap (CAST) Method: TM9SF3 Participates in Tumor Invasion and Serves as a Prognostic Factor , 2014, Pathobiology.

[3]  K. Yamashita,et al.  Simple prognostic indicators using macroscopic features and age in advanced gastric cancer. , 2014, Hepato-gastroenterology.

[4]  K. Yanagihara,et al.  MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer , 2014, Cancer science.

[5]  L. Castro,et al.  Type IV Borrmann gastric adenocarcinoma: analysis of curative resection results. , 2011, Revista do Colegio Brasileiro de Cirurgioes.

[6]  W. Knoefel,et al.  Prognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatment , 2011, European journal of medical research.

[7]  F. Roviello,et al.  Gastric linitis plastica: which role for surgical resection? , 2011, Gastric Cancer.

[8]  H. Hur,et al.  Predicting factors of unexpected peritoneal seeding in locally advanced gastric cancer: Indications for staging laparoscopy , 2010, Journal of surgical oncology.

[9]  Zhenggang Zhu,et al.  Macroscopic Borrmann Type as a Simple Prognostic Indicator in Patients with Advanced Gastric Cancer , 2009, Oncology.

[10]  J. Yook,et al.  Clinicopathological analysis of Borrmann type IV gastric cancer. , 2005, Cancer research and treatment : official journal of Korean Cancer Association.

[11]  F. Greene.  AJCC cancer staging handbook , 2002 .

[12]  A. Terano,et al.  Identification of the Prelinitis Condition in Gastric Cancer and Analysis of TGF-β, TGF-β RII and pS2 Expression , 2002, Pathobiology.

[13]  Y. Kodera,et al.  Is Borrmann type IV gastric carcinoma a surgical disease? An old problem revisited with reference to the result of peritoneal washing cytology , 2001, Journal of surgical oncology.

[14]  T. Yoshikawa,et al.  Should scirrhous gastric carcinoma be treated surgically? Clinical experiences with 233 cases and a retrospective analysis of prognosticators. , 2001, Hepato-gastroenterology.

[15]  T. Inoue,et al.  TGF-beta1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells. , 2000, International journal of oncology.

[16]  M. Iki,et al.  Association between Tumor Angiogenesis and Borrmann Type 4 Carcinomas of the Stomach , 1998, Oncology.

[17]  K. Sugimachi,et al.  Clinicopathologic study of patients with Borrmann type iv gastric carcinoma , 1995, Journal of surgical oncology.

[18]  R. Takimoto,et al.  Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue. , 1994, British Journal of Cancer.

[19]  Y. Maehara,et al.  Lower survival rate for patients with carcinoma of the stomach of Borrmann type IV after gastric resection. , 1992, Surgery, gynecology & obstetrics.